Werblińska B, Fleming A F
Ann Trop Med Parasitol. 1979 Apr;73(2):149-59. doi: 10.1080/00034983.1979.11687242.
Treatment of severe iron deficiency with iron-poly(sorbitol-gluconic acid) complex (Ferastral) intramuscular 10 ml (iron 500 mg) on alternate days has been shown highly effective and well tolerated. In order to see whether the time of treatment could be shortened, 20 Nigerians with severe iron deficiency (mostly from hookworm infection) were treated with daily intramuscular Ferastral 10 ml until their calculated total requirement of iron was met. The total iron deficit was 877-2763 mg (mean 1875 mg). Supportive treatment included antimalarials, folic acid and anthelmintics. No patient complained of undue pain at injection sites or of any other undesirable side-effects. There was no evidence of hepatic or renal toxicity in any patient, including eight who were followed at intervals up to eight weeks from the start of treatment. The initial haemoglobin (Hb) level was 2.2-7.8 g/dl (mean 4.6 g/dl). Daily regeneration of Hb in the first 14 days was 0.12-0.49 g/dl (mean 0.30 g/dl), and haematological indices were generally normal by eight weeks. Recovery was slow or incomplete in six patients, all of whom had complications other than iron deficiency. Serum iron was measured in five patients, rose to around 8000 micrograms/dl on about day 4, and fell to physiological levels by day 14. The serum unsaturated iron binding capacity fell to nil in five out of six patients on around day 3, and reappeared between days 7 and 10. Five patients who had persistent blood loss from continued hookworm infestation received a further single dose of Ferastral (iron 1000 mg) 10 ml into each buttock after four weeks, and one patient after two weeks. This large dose was also acceptable to patients if given slowly; it was followed by an accelerated Hb regeneration, but no toxicity. Daily intramuscular Ferastral 10 ml until the calculated iron requirements are met (usually in less than five days) is recommended for the treatment of severe iron deficiency. Patients with continued blood loss or Hb less than 10 g/dl after four weeks without other cause of anaemia, may receive a boost of one intramuscular injection of Ferastral 20 ml (10 ml into each buttock).
用聚山梨醇 - 葡萄糖酸铁复合物(Ferastral)10毫升(含铁500毫克)隔日肌内注射治疗严重缺铁已显示出高效且耐受性良好。为了探究治疗时间是否可以缩短,对20名严重缺铁的尼日利亚人(大多因钩虫感染所致)进行每日肌内注射10毫升Ferastral的治疗,直至达到他们计算出的铁总需求量。铁总缺乏量为877 - 2763毫克(平均1875毫克)。支持性治疗包括抗疟药、叶酸和驱虫药。没有患者抱怨注射部位有过度疼痛或任何其他不良副作用。没有任何患者出现肝或肾毒性的迹象,包括8名从治疗开始起每隔一段时间随访至8周的患者。初始血红蛋白(Hb)水平为2.2 - 7.8克/分升(平均4.6克/分升)。在最初14天内血红蛋白每日再生量为0.12 - 0.49克/分升(平均0.30克/分升),到8周时血液学指标总体正常。6名患者恢复缓慢或不完全,他们均有除缺铁外的其他并发症。对5名患者测量了血清铁,在大约第4天时升至约8000微克/分升,到第14天时降至生理水平。6名患者中有5名在大约第3天时血清未饱和铁结合能力降至零,并在第7天至第10天之间再次出现。5名因持续钩虫感染而持续失血的患者在4周后每侧臀部再接受一次10毫升Ferastral(含铁1000毫克)的单次注射,1名患者在2周后接受。如果缓慢注射,这种大剂量对患者也是可以接受的;随后血红蛋白再生加速,但无毒性。建议每日肌内注射10毫升Ferastral直至达到计算出的铁需求量(通常在不到5天内)用于治疗严重缺铁。4周后持续失血或血红蛋白低于10克/分升且无其他贫血原因的患者,可额外接受一次20毫升Ferastral(每侧臀部10毫升)的肌内注射。